Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma

Published:2018-02-17 Issue:2 Volume:50 Page:304-307
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Asadi Milad,Shanehbandi Dariush,Mohammadpour Hanieh,Hashemzadeh Shahriyar,Sepehri Bita

Funder

Tabriz University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/article/10.1007/s12029-018-0060-0/fulltext.html

Reference33 articles.

1. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(7498):91–5. https://doi.org/10.1038/nature13176.

2. Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE. Gastrointestinal oncology: principles and practice. Philadelphia: Lippincott Williams and Wilkins; 2002.

3. Schottenfeld D. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. https://doi.org/10.1093/acprof:oso/9780195149616.001.0001.

4. Zhang H-Z, Jin G-F, Shen H-B. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–6. https://doi.org/10.5732/cjc.011.10390.

5. Akhtar S. Areca nut chewing and esophageal squamous-cell carcinoma risk in Asians: a meta-analysis of case–control studies. Cancer Causes Control. 2013;24(2):257–65. https://doi.org/10.1007/s10552-012-0113-9.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Intensity Interval Training Protectively Modulates Doxorubicin- Induced Changes in Cardiac Mitochondrial Dynamics and Autophagy Process;2024-09-02

2. MicroRNA-34 and gastrointestinal cancers: a player with big functions;Cancer Cell International;2024-05-09

3. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential;Cancers;2023-09-26

4. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches;Cell Biology and Toxicology;2023-06-20

5. The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer;Pathology - Research and Practice;2023-06